News

Filter

Current filters:

DepomedFinancial

Depomed regains rights to Gralise from Abbott; licenses Acuform to Boehringer Ingelheim

18-03-2011

Following a period of mediation, USA-based Depomed (Nasdaq: DEPO) will regain rights to its shingles…

Abbott LaboratoriesAnti-viralsBoehringer IngelheimDepomedDiabetesFinancialGlumetzaGraliseLicensingPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top